[C-11]PIB PET imaging can detect white and grey matter demyelination in a non-human primate model of progressive multiple sclerosis

Autor(es):Mostrar menos -

Carvalho, Robert H. F. ^[1] ; Real, Caroline C. ^[1] ; Cinini, Simone ^[2] ; Garcez, Alexandre T. ^[1] ; Duran, Fabio L. S. ^[3] ; Marques, Fabio L. N. ^[1] ; Mello, Luiz Eugenio ^[2] ; Busatto Filho, Geraldo ^[3] ; de Vries, Erik F. J. ^[4] ; de Britto, Luiz R. G. ^[5] ; Buchpiguel, Carlos A. ^[1] ; Faria, Daniele de Paula ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Lab Nucl Med LIM 43, Sao Paulo, SP - Brazil

^[2] Univ Fed Sao Paulo, Dept Physiol, Escola Paulista Med, Sao Paulo, SP - Brazil

^[3] Univ Sao Paulo, Fac Med, Dept Psiquiatria, Lab Psychiat Neuroimaging LIM 21, Sao Paulo, SP - Brazil

^[4] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen - Netherlands

^[5] Univ Sao Paulo, Dept Fisiol & Biofis, Lab Cellular Neurobiol, Sao Paulo, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: MULTIPLE SCLEROSIS AND RELATED DISORDERS; v. 35, p. 108-115, OCT 2019.
• Citações Web of Science: 0

Resumo

Background: Multiple sclerosis (MS) is a demyelinating and inflammatory disease of the central nervous system. Its diagnosis is clinical, often confirmed by magnetic resonance imaging. This image modality, however, is not ideal for discrimination of demyelination in grey and white matter regions from inflammatory lesions. Positron Emission Tomography (PET), using specific radiopharmaceuticals, can be a tool to differentiate between these processes. The radiopharmaceutical {[}C-11]PIB is widely used for detection of beta-amyloid plaques, but has also been suggested for the analysis of myelin content due to its consistent uptake in white matter. The aim of this study was to evaluate {[}C-11]PIB PET imaging as a tool for detecting demyelinated regions in white and grey matter of non-human primate model of progressive MS. Methods: Experimental autoimmune encephalomyelitis (EAE) was induced in marmosets by injection of re-combinant human myelin oligodendrocyte glycoprotein (rhMOG) emulsified in either Incomplete Freund's Adjuvant (IFA) or Complete Freund's Adjuvant (CFA). {[}C-11]PIB PET images were acquired prior to immunization (baseline) and after symptoms were present (end of experiment). Brain tissue was isolated for histochemical analysis. Results: All rhMOG/IFA-treated and rhMOG/CFA-treated animals showed clinical signs of EAE. The rhMOG/CFA group presented a significant {[}C-11]PIB uptake reduction only in the left motor cortex (9%, P = 0.011). For the rhMOG/IFA group, significant decrease in {[}C-11]PIB uptake was observed in the whole brain (15%, P = 0.015), in the right hemisphere of body of corpus callosum (34%, P = 0.02), splenium of corpus callosum (38%, P = 0.004), hippocampus (19%, P = 0.036), optic tract (13%, P = 0.025), thalamus (14%, P = 0.041), Globus pallidus (23%, P = 0.017), head of caudate nucleus (25%, P = 0.045), tail of caudate nucleus (29%, P = 0.003), putamen (28%, P = 0.047) and left hemisphere of body of corpus callosum (14%, P = 0.037) and head of caudate nucleus (23%, P = 0.023). {[}C-11]PIB uptake significantly correlated with luxol fast blue histology (myelin marker), both in the rhMOG/IFA (r(2) = 0.32, P < 0.0001) and the rhMOG/CFA group (r(2) = 0.46, P < 0.0001). Conclusion: {[}C-11]PIB PET imaging is an efficient tool for detecting demyelination in grey and white matter, in a non-human primate model of progressive MS. (AU)

• Processo FAPESP: 13/25049-2 - Correlação de parâmetros celulares, moleculares, comportamentais e neurofuncionais na Doença de Parkinson com o exercício físico em modelo animal e em tecido humano postmortem
• Beneficiário: Caroline Cristiano Real Gregório
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado